Evelyn Partners Asset Management Ltd
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2065207
London, X0
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,987
-$320 QoQ
Shares Held
47
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Evelyn Partners Asset Management Ltd holds $54,925 across 2 Biotechnology names. VRTX ranks #2 (38.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FHTX |
Foghorn Therapeutics Inc.
|
7,100 | $33,938 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
47 | $20,987 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,987 | 47 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,307 | 47 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,407 | 47 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,006 | 9 | Shares | Sole | 2025-11-26 | |
| 2025-03-31 | $4,363 | 9 | Shares | Sole | 2025-12-08 | |
| 2024-12-31 | $3,624 | 9 | Shares | Sole | 2025-12-11 | |
| No filing history on record for this holder in this stock. | ||||||